Multicentre, Randomized, Double-blind, Placebo-controlled Study of Safety and Efficacy of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome® Gel) for the Treatment of Osteoarthritis of the Knee

NCT00722852 Phase 3 COMPLETED

The purpose of this study is to provide replicated evidence of safety and efficacy of 100 mg ketoprofen in Diractin®.

Details

Lead sponsor	IDEA AG
Phase	Phase 3
Status	COMPLETED
Enrolment	555
Start date	2008-06
Completion	2009-04

Conditions

• Osteoarthritis of the Knee

Interventions

• ketoprofen in Diractin®
• Placebo

Primary outcomes

• pain subscale of the WOMAC — week 12

Countries

United States